Literature DB >> 6468393

Biological activities of analogues of lipid A based chemically on the revised structural model. Comparison of mediator-inducing, immunomodulating and endotoxic activities.

S Kanegasaki, Y Kojima, M Matsuura, J Y Homma, A Yamamoto, Y Kumazawa, K Tanamoto, T Yasuda, T Tsumita, M Imoto.   

Abstract

Lipid A analogues were chemically synthesized based on the model structure recently revised, and biological activities of the analogues were tested. The analogue, (beta-1,6)-linked glucosamine disaccharide carrying ester-bound 3-hydroxytetradecanoic acids at 3 and 3' position of reducing and nonreducing glucosamine in addition to amide-bound 3-hydroxytetradecanoic acids and glycosidic-linked and ester-linked phosphate groups, showed much stronger activities for mediator inducing and immunomodulating as well as endotoxic activities than those exhibited by the previously synthesized analogues based on the old model. Among the activities tested, induction of interferon and tumor necrosis factor as well as mitogenicity, adjuvanticity and pyrogenicity were, however, not expressed so strongly as natural lipid A used as controls. In contrast, the analogue exhibited comparable activities to those of control lipid A in the test of lethal toxicity to mice and gelating activity of Limulus amebocyte lysate. Other synthetic analogues carrying a phosphate group showed comparable, slightly stronger or weaker activities depending on the test, but nonphosphorylated analogue exhibited no apparent or only very weak activities.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6468393     DOI: 10.1111/j.1432-1033.1984.tb08364.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  18 in total

1.  Physical contact between lipopolysaccharide and toll-like receptor 4 revealed by genetic complementation.

Authors:  A Poltorak; P Ricciardi-Castagnoli; S Citterio; B Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

2.  A statistical model for activation of Factor C by binding to LPS aggregates.

Authors:  Y Miyagawa; K Kikuchi; M Tsuchiya; S Adachi
Journal:  Eur Biophys J       Date:  2019-10-19       Impact factor: 1.733

3.  Dissociation of endotoxic activities in a chemically synthesized lipid A precursor after acetylation.

Authors:  K Tanamoto
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

4.  Low biological activity of Helicobacter pylori lipopolysaccharide.

Authors:  A Muotiala; I M Helander; L Pyhälä; T U Kosunen; A P Moran
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

5.  Requirement of a properly acylated beta(1-6)-D-glucosamine disaccharide bisphosphate structure for efficient manifestation of full endotoxic and associated bioactivities of lipid A.

Authors:  I Takahashi; S Kotani; H Takada; M Tsujimoto; T Ogawa; T Shiba; S Kusumoto; M Yamamoto; A Hasegawa; M Kiso
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

6.  Immunobiological activities of synthetic lipid A analogs with low endotoxicity.

Authors:  S Kotani; H Takada; I Takahashi; T Ogawa; M Tsujimoto; H Shimauchi; T Ikeda; H Okamura; T Tamura; K Harada
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

7.  Endotoxic induction of prostaglandin release from macrophages by nontoxic lipid A analogs synthesized chemically.

Authors:  K Tanamoto; U Shade; E T Rietschel; S Kusumuto; T Shiba
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

8.  Free hydroxyl groups are not required for endotoxic activity of lipid A.

Authors:  K Tanamoto
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

9.  Synthetic Salmonella-type lipid A antigen with high serological specificity.

Authors:  N Kasai; S Arata; J Mashimo; K Okuda; Y Aihara; S Kotani; H Takada; T Shiba; S Kusumoto; M Imoto
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

Review 10.  Molecular adjuvants and immunomodulators: new approaches to immunization.

Authors:  A G Johnson
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.